Prescient Therapeutics LimitedASX: PTX

1st patient dosed in trial for first in class drug PTX-100

Nov 14, 2019 at 3:23 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment